Consolidated Income Statement

Sales

2,905.6

2,659.5

8,315.0

8,063.8

Royalty, license and commission income

30.8

92.3

149.4

289.6

Total revenues

2,936.4

2,751.8

8,464.4

8,353.4

Cost of sales

–948.2

–735.5

–2,538.3

–2,252.0

(of which: amortization of intangible assets)¹

(–30.0)

(–12.1)

(–54.9)

(–36.7)

Gross profit

1,988.2

2,016.3

5,926.1

6,101.3

Marketing and selling expenses

–760.7

–745.7

–2,280.4

–2,324.6

(of which: amortization of intangible assets)¹

(–176.2)

(–185.6)

(–544.8)

(–580.0)

Royalty, license and commission expenses

–134.4

–144.4

–409.9

–437.2

Administration expenses

–156.0

–136.7

–439.3

–407.0

Other operating expenses and income

–4.4

–128.4

–181.6

–426.9

Research and development costs

–503.8

–379.3

–1,276.8

–1,159.1

Operating result (EBIT)

428.9

481.8

1,338.2

1,346.6

Financial result

–57.2

–51.9

–142.2

–159.1

Profit before income tax

371.7

430.0

1,196.0

1,187.5

Income tax

–122.1

–87.4

–313.1

–259.9

Profit after tax

249.6

342.5

883.0

927.6

of which attributable to Merck KGaA shareholders
(net income)

248.8

339.6

877.3

921.6

of which attributable to non-controlling interests

0.8

3.0

5.7

6.0

basic²

0.57

0.78

2.02

2.12

diluted²

0.57

0.78

2.02

2.12